-
Symbol
-
TERN on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Ownership
-
5.7M shares
-
Security Ownership
-
6.5%
Shares, Excluding Options vs Price
Value, Excluding Options
Commodore Capital LP ownership in Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN)
2025-11-14 - Commodore Capital LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.7M shares of Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN).
This represents 6.5% percent ownership of the company.
In their previous filing dated 2025-09-16, COMMODORE CAPITAL LP had reported owning 4.65M shares, indicating an increase of 22.6% percent.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.